Cell Surface Differentiation Antigens of the Malignant T Cell in Sezary Syndrome and Mycosis Fungoides

AUTOR(ES)

Haynes, Barton F.

RESUMO

Using a panel of monoclonal antibodies and rabbit heteroantisera, we have studied the cell surface markers of peripheral blood (PB) Sezary cells from six patients with mycosis fungoides or Sezary syndrome, disease grouped within the spectrum of cutaneous T cell lymphomas (CTCL). Furthermore, we have studied two cell lines (Hut 78 and Hut 102) derived from malignant Sezary T cells from CTCL patients. The monoclonal antibody 3A1 defines a major human PB T cell subset (85% of PB T cells) while the antigen defined by the monoclonal antibody 4F2 is present on a subset (70%) of activated PB T cells and on circulating PB monocytes.

Documentos Relacionados

• Mycosis fungoides and Sézary syndrome: focus on the current treatment scenario
• DNA Content Analysis by Flow Cytometry and Cytogenetic Analysis in Mycosis Fungoides and Sézary Syndrome: DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS
• The Sézary syndrome: a malignant proliferation of helper T cells.
• Aplicabilidade da classificação WHO 2008 para os linfomas de células T não-micose fungóide/síndrome de Sézary com expressão primária cutânea
• Mycosis Fungoides